Greenspring Associates’s Zai Lab ZLAB Stock Holding History

Greenspring Associates’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-551	Closed	-$18K	–	21
2019 Q3	$18K	Buy	+551	New	+$18.9K	0.01%	14

Other funds holding ZLAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greenspring Associates's ZLAB Position: Q4 2019 in Review

Greenspring Associates sold out of Zai Lab (ZLAB) in Q4 2019, closing a stake of 551 shares — an estimated $18K sold.

Greenspring Associates first reported a position in ZLAB in Q3 2019 and held it in 1 quarter. The position peaked at $18K in Q3 2019. 104 funds tracked by Wall St. Rank hold ZLAB as of Q4 2019.

Greenspring Associates reported no remaining Zai Lab position as of Q4 2019 after selling out during the quarter.
Greenspring Associates sold 551 Zai Lab shares in Q4 2019, an estimated $18K.
Greenspring Associates first reported a position in Zai Lab in Q3 2019 and held it in 1 quarter.
Greenspring Associates's Zai Lab position peaked at $18K in Q3 2019.
104 funds tracked by Wall St. Rank held Zai Lab as of Q4 2019.

Based on Greenspring Associates's 13F filing for Q4 2019, filed 14 Feb 2020.